vs
太平洋生物科学（ASMB）与Axil Brands, Inc.（AXIL）财务数据对比。点击上方公司名可切换其他公司
太平洋生物科学的季度营收约是Axil Brands, Inc.的1.3倍（$10.8M vs $8.1M），Axil Brands, Inc.净利率更高（8.7% vs -85.2%，领先93.9%），太平洋生物科学同比增速更快（57.6% vs 5.2%），Axil Brands, Inc.自由现金流更多（$906.4K vs $-15.2M）
该公司是一家成立于2004年的美国生物科技企业，主要研发生产基因测序相关设备，同时也开展新型实时生物观测技术相关业务。目前拥有两大核心测序平台，分别是基于零模波导特性的单分子实时测序平台，以及结合天然核苷酸无痕连接技术的结合测序平台。
Axil Brands是一家总部位于美国的专业消费电子企业，主营高端听力防护设备、音频增强装置及个性化音频配件，旗下产品涵盖定制耳塞、运动蓝牙耳机等，面向全球普通消费者及专业作业群体销售。
ASMB vs AXIL — 直观对比
营收规模更大
ASMB
是对方的1.3倍
$8.1M
营收增速更快
ASMB
高出52.4%
5.2%
净利率更高
AXIL
高出93.9%
-85.2%
自由现金流更多
AXIL
多$16.1M
$-15.2M
损益表 — Q3 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $10.8M | $8.1M |
| 净利润 | $-9.2M | $704.9K |
| 毛利率 | — | 68.1% |
| 营业利润率 | -100.9% | 11.1% |
| 净利率 | -85.2% | 8.7% |
| 营收同比 | 57.6% | 5.2% |
| 净利润同比 | 4.3% | 11.2% |
| 每股收益（稀释后） | $-0.72 | $0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASMBAXIL
| Q4 25 | — | $8.1M | ||
| Q3 25 | $10.8M | $6.9M | ||
| Q2 25 | $9.6M | $5.8M | ||
| Q1 25 | $9.4M | $6.9M | ||
| Q4 24 | $7.4M | $7.7M | ||
| Q3 24 | $6.8M | $5.9M | ||
| Q2 24 | $8.5M | $6.5M | ||
| Q1 24 | $5.8M | $6.5M |
净利润ASMBAXIL
| Q4 25 | — | $704.9K | ||
| Q3 25 | $-9.2M | $334.3K | ||
| Q2 25 | $-10.2M | $-245.6K | ||
| Q1 25 | $-8.8M | $576.7K | ||
| Q4 24 | — | $633.7K | ||
| Q3 24 | $-9.6M | $-109.8K | ||
| Q2 24 | $-11.2M | $49.5K | ||
| Q1 24 | $-9.1M | $781.1K |
毛利率ASMBAXIL
| Q4 25 | — | 68.1% | ||
| Q3 25 | — | 67.6% | ||
| Q2 25 | — | 70.0% | ||
| Q1 25 | — | 71.7% | ||
| Q4 24 | — | 71.1% | ||
| Q3 24 | — | 71.0% | ||
| Q2 24 | — | 71.5% | ||
| Q1 24 | — | 71.5% |
营业利润率ASMBAXIL
| Q4 25 | — | 11.1% | ||
| Q3 25 | -100.9% | 6.0% | ||
| Q2 25 | -115.2% | 0.8% | ||
| Q1 25 | -105.5% | 8.4% | ||
| Q4 24 | — | 8.7% | ||
| Q3 24 | -160.1% | -2.4% | ||
| Q2 24 | -143.0% | 2.6% | ||
| Q1 24 | -185.5% | -1.6% |
净利率ASMBAXIL
| Q4 25 | — | 8.7% | ||
| Q3 25 | -85.2% | 4.9% | ||
| Q2 25 | -105.9% | -4.3% | ||
| Q1 25 | -93.6% | 8.3% | ||
| Q4 24 | — | 8.2% | ||
| Q3 24 | -140.4% | -1.9% | ||
| Q2 24 | -130.7% | 0.8% | ||
| Q1 24 | -156.9% | 12.1% |
每股收益（稀释后）ASMBAXIL
| Q4 25 | — | $0.09 | ||
| Q3 25 | $-0.72 | $0.04 | ||
| Q2 25 | $-1.33 | $-0.03 | ||
| Q1 25 | $-1.17 | $0.07 | ||
| Q4 24 | — | $0.08 | ||
| Q3 24 | $-1.51 | $-0.02 | ||
| Q2 24 | $-1.98 | $0.11 | ||
| Q1 24 | $-1.66 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $22.5M | $5.0M |
| 总债务越低越好 | — | $138.3K |
| 股东权益账面价值 | $182.7M | $11.1M |
| 总资产 | $240.0M | $16.2M |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
现金及短期投资ASMBAXIL
| Q4 25 | — | $5.0M | ||
| Q3 25 | $22.5M | $4.1M | ||
| Q2 25 | $24.0M | $4.8M | ||
| Q1 25 | $23.4M | $4.7M | ||
| Q4 24 | $38.3M | $5.2M | ||
| Q3 24 | $28.5M | $4.1M | ||
| Q2 24 | $19.2M | $3.3M | ||
| Q1 24 | $18.7M | $4.9M |
总债务ASMBAXIL
| Q4 25 | — | $138.3K | ||
| Q3 25 | — | $139.2K | ||
| Q2 25 | — | $140.2K | ||
| Q1 25 | — | $141.0K | ||
| Q4 24 | — | $143.3K | ||
| Q3 24 | — | $144.3K | ||
| Q2 24 | — | $146.6K | ||
| Q1 24 | — | — |
股东权益ASMBAXIL
| Q4 25 | — | $11.1M | ||
| Q3 25 | $182.7M | $10.2M | ||
| Q2 25 | $18.1M | $9.7M | ||
| Q1 25 | $27.1M | $9.7M | ||
| Q4 24 | $33.4M | $8.8M | ||
| Q3 24 | $26.0M | $7.9M | ||
| Q2 24 | $34.7M | $7.7M | ||
| Q1 24 | $32.6M | $8.8M |
总资产ASMBAXIL
| Q4 25 | — | $16.2M | ||
| Q3 25 | $240.0M | $15.4M | ||
| Q2 25 | $80.8M | $12.9M | ||
| Q1 25 | $99.0M | $13.0M | ||
| Q4 24 | $119.2M | $13.7M | ||
| Q3 24 | $100.3M | $11.4M | ||
| Q2 24 | $115.3M | $11.0M | ||
| Q1 24 | $119.9M | $12.7M |
负债/权益比ASMBAXIL
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.01× | ||
| Q1 25 | — | 0.01× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.02× | ||
| Q2 24 | — | 0.02× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-15.1M | $934.8K |
| 自由现金流经营现金流 - 资本支出 | $-15.2M | $906.4K |
| 自由现金流率自由现金流/营收 | -140.7% | 11.1% |
| 资本支出强度资本支出/营收 | 0.4% | 0.3% |
| 现金转化率经营现金流/净利润 | — | 1.33× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ASMBAXIL
| Q4 25 | — | $934.8K | ||
| Q3 25 | $-15.1M | $-739.2K | ||
| Q2 25 | $-16.8M | $194.4K | ||
| Q1 25 | $-23.4M | $-169.9K | ||
| Q4 24 | $-51.1M | $1.0M | ||
| Q3 24 | $-15.2M | $897.3K | ||
| Q2 24 | $-17.1M | $-336.6K | ||
| Q1 24 | $-18.4M | $-912.8K |
自由现金流ASMBAXIL
| Q4 25 | — | $906.4K | ||
| Q3 25 | $-15.2M | $-747.6K | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $-258.2K | ||
| Q4 24 | $-51.1M | $941.1K | ||
| Q3 24 | — | — | ||
| Q2 24 | $-17.1M | $-394.9K | ||
| Q1 24 | $-18.4M | $-922.1K |
自由现金流率ASMBAXIL
| Q4 25 | — | 11.1% | ||
| Q3 25 | -140.7% | -10.9% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -3.7% | ||
| Q4 24 | -695.2% | 12.2% | ||
| Q3 24 | — | — | ||
| Q2 24 | -200.6% | -6.1% | ||
| Q1 24 | -317.7% | -14.3% |
资本支出强度ASMBAXIL
| Q4 25 | — | 0.3% | ||
| Q3 25 | 0.4% | 0.1% | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.0% | 1.3% | ||
| Q4 24 | 0.4% | 0.9% | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.2% | 0.9% | ||
| Q1 24 | 0.2% | 0.1% |
现金转化率ASMBAXIL
| Q4 25 | — | 1.33× | ||
| Q3 25 | — | -2.21× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -0.29× | ||
| Q4 24 | — | 1.59× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -6.80× | ||
| Q1 24 | — | -1.17× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASMB
暂无分部数据
AXIL
| Hearing Enhancement And Protection | $7.8M | 95% |
| Other | $378.9K | 5% |
